Generation of an RNF1-deficient human pluripotent stem cell line using CRISPR/Cas9 technology

Di Zhang1, Min Zhou2, Yanqi Zhang1

  • 1CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Stem Cell Research
|May 14, 2022
PubMed